ocrevus
(ocrelizumab)Genentech, Inc.
Usage: OCREVUS is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as primary progressive MS in adults.